ASH: Rivaroxaban Prevents Blood Clots in At-Risk Cancer Patients

WEDNESDAY, Dec. 5, 2018 -- Rivaroxaban can prevent venous thromboembolism (VTE) in cancer patients at increased risk, according to a study presented at the annual meeting of the American Society of Hematology, held from Dec. 1 to 4 in San...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news